Compare · CHPT vs SNN
CHPT vs SNN
Side-by-side comparison of ChargePoint Holdings Inc. (CHPT) and Smith & Nephew SNATS Inc. (SNN): market cap, price performance, sector, and recent activity on the wire.
Summary
- CHPT operates in Consumer Discretionary, while SNN operates in Health Care - the two are in different parts of the market.
- SNN is the larger of the two at $12.41B, about 82.1x CHPT ($151.2M).
- Over the past year, CHPT is down 49.6% and SNN is down 21.7% - SNN leads by 27.9 points.
- SNN has been more active in the news (14 items in the past 4 weeks vs 3 for CHPT).
- Both have 25 recent analyst ratings on file.
- Company
- ChargePoint Holdings Inc.
- Smith & Nephew SNATS Inc.
- Price
- $5.83-1.69%
- $29.21-1.43%
- Market cap
- $151.2M
- $12.41B
- 1M return
- +7.76%
- -6.18%
- 1Y return
- -49.57%
- -21.68%
- Industry
- Industrial Specialties
- Industrial Specialties
- Exchange
- NYSE
- NYSE
- IPO
- 2019
- News (4w)
- 3
- 14
- Recent ratings
- 25
- 25
ChargePoint Holdings Inc.
ChargePoint Holdings, Inc. provides electric vehicle (EV) charging networks and charging solutions in the United States. It offers a portfolio of hardware, software, and services for commercial, fleet, and residential customers. The company was founded in 2007 and is headquartered in Campbell, California.
Smith & Nephew SNATS Inc.
Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices worldwide. The company offers knee implant products for knee replacement procedures; hip implants for the reconstruction of hip joints; and trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures. It also provides sports medicine joint repair products for surgeons, including instruments, technologies, and implants necessary to perform minimally invasive surgery of the joints, such as the repair of soft tissue injuries and degenerative conditions of the knee, hip, and shoulder, as well as meniscal repair systems. In addition, the company offers arthroscopic enabling technologies comprising fluid management equipment for surgical access, high definition cameras, digital image capture, scopes, light sources, and monitors to assist with visualization inside the joints, radio frequency, electromechanical and mechanical tissue resection devices, and hand instruments for removing damaged tissue; and ear, nose, and throat solutions. Further, it provides advanced wound care products for the treatment and prevention of acute and chronic wounds, which comprise leg, diabetic and pressure ulcers, burns, and post-operative wounds; advanced wound bioactives, including biologics and other bioactive technologies for debridement and dermal repair/regeneration, as well as regenerative medicine products including skin, bone graft, and articular cartilage substitutes; and advanced wound devices, such as traditional and single-use negative pressure wound therapy, and hydrosurgery systems. It primarily serves the healthcare providers. The company was founded in 1856 and is headquartered in Watford, the United Kingdom.
Latest CHPT
- ChargePoint to Announce Second Quarter Fiscal Year 2027 Financial Results on September 2, 2026
- ChargePoint and Portland International Airport Set New Standard for Rental Car Electrification with Industry-Leading Overhead Fast Charging
- ChargePoint and Mercedes-Benz Partner to Simplify Fleet Electrification with End-to-End Charging Solutions
- ChargePoint Holdings Inc. filed SEC Form 8-K: Costs Associated with Exit or Disposal Activities, Leadership Update, Regulation FD Disclosure
- Director Singh-Bushell Ekta was granted 25,050 shares, increasing direct ownership by 122% to 45,627 units (SEC Form 4)
- Director Heystee Susan was granted 25,050 shares, increasing direct ownership by 120% to 45,945 units (SEC Form 4)
- Director Linse Michael was granted 27,555 shares, increasing direct ownership by 129% to 48,930 units (SEC Form 4)
- Director Leschly Mark was granted 26,386 shares, increasing direct ownership by 123% to 47,761 units (SEC Form 4)
- Director Harris Jeffrey was granted 28,390 shares, increasing direct ownership by 133% to 49,765 units (SEC Form 4)
- Director Harries Axel was granted 25,050 shares, increasing direct ownership by 117% to 46,425 units (SEC Form 4)
Latest SNN
- SEC Form 6-K filed by Smith & Nephew SNATS Inc.
- SEC Form 6-K filed by Smith & Nephew SNATS Inc.
- SEC Form 6-K filed by Smith & Nephew SNATS Inc.
- Smith+Nephew and Imperial College London launch centre to accelerate innovation in surgical robotics
- Smith+Nephew’s new FLOW FLEXTEND™ COBLATION™ Wand improves access¹* and resection efficiency²** for complex hip procedures vs. fixed-angle options
- SEC Form 6-K filed by Smith & Nephew SNATS Inc.
- SEC Form 6-K filed by Smith & Nephew SNATS Inc.
- SEC Form 6-K filed by Smith & Nephew SNATS Inc.
- Smith & Nephew downgraded by Analyst
- Smith+Nephew celebrates mobility, recovery and football's greatest traditions during Pro Football Hall of Fame Enshrinement Week